You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Claims for Patent: 5,700,774

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 5,700,774

Title:	Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same
Abstract:	Compositions of proteins with chondrocyte and cartilaginous tissue inducing activity, as well as method of using those compositions, are disclosed. The compositions comprise one or more proteins of the transforming growth factor-.beta. (TGF-.beta.) superfamily of proteins, particularly bone morphogenetic proteins (BMPs), in combination with parathyroid hormone related polypeptide (PTHrP) or an equivalent PTH-like polypeptide. The compositions and methods are useful in the treatment of osteoarthritis, cartilage defects and in related tissue repair.
Inventor(s):	Hattersley; Gary (Cambridge, MA), Rosen; Vicki A. (Chestnut Hill, MA)
Assignee:	Genetics Institute, Inc. (Cambridge, MA)
Application Number:	08/622,101
Patent Claims:	1. A composition comprising: (a) at least one protein member of the bone morphogenetic protein (BMP) family of proteins; and (b) a truncated parathyroid hormone related peptide (PTHrP) comprising amino acids 1 to 34 of PTHrP; said composition having the activity of inducing the formation or maintenance of cartilaginous tissue in a patient when administered to said patient. 2. The composition of claim 1, wherein the bone morphogenetic protein is selected from the group consisting of BMP-2, BMP-4, BMP-5, BMP-7, BMP-12 and BMP-13. 3. The composition of claim 2, wherein the bone morphogenetic protein is BMP-2. 4. The composition of claim 3, wherein said composition further comprises one or more additional proteins which are members of the BMP subfamily of proteins. 5. The composition of claim 4, wherein the additional proteins are selected from the group consisting of BMP-4, BMP-5, BMP-7, BMP-12 and BMP-13. 6. The composition of claim 2, wherein the bone morphogenetic protein is BMP-13. 7. The composition of claim 6, wherein said composition further comprises one or more additional proteins which are members of the BMP subfamily of proteins. 8. The composition of claim 7, wherein the additional proteins are selected from the group consisting of BMP-2, BMP-4, BMP-5, BMP-7 and BMP-12. 9. A method for inducing the formation or maintenance of cartilaginous tissue in a patient, comprising administering to the patient an effective amount of the composition of claim 1. 10. A method according to claim 9, wherein the patient is suffering from arthritis. 11. A method according to claim 9, wherein the patient is suffering from an articular cartilage defect or damage. 12. A composition comprising: (a) at least one protein member of the transforming growth factor-.beta. (TGF-.beta.) superfamily selected from the group consisting of Bone Morphogenetic Protein-2 (BMP-2), Bone Morphogenetic Protein-13 (BMP-13), heterodimers of BMP-2 and BMP-13 and combinations of the above; and (b) a truncated parathyroid hormone related peptide (PTHrP) comprising amino acids 1 to 34 of PTHrP; said composition having the activity of inducing the formation or maintenance of cartilaginous tissue in a patient when administered to said patient. 13. The composition of claim 12 wherein the TGF-.beta. superfamily member is BMP-2. 14. The composition of claim 12 wherein the TGF-.beta. superfamily member is BMP -13. 15. A method for inducing the formation or maintenance of cartilaginous tissue in a patient, comprising administering to the patient an effective amount of the composition of claim 12. 16. A method according to claim 15, wherein the patient is suffering from arthritis. 17. A method according to claim 15, wherein the patient is suffering from an articular cartilage defect or damage.

Details for Patent 5,700,774

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Nps Pharmaceuticals, Inc.	NATPARA	parathyroid hormone	For Injection	125511	01/23/2015	⤷ Try a Trial	2039-03-29
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.